Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2022 Financial Results
February 27, 2023 16:30 ET
|
Recursion Pharmaceuticals
Initiated five clinical trials in 2022, including three Phase 2 programs, and provided guidance on the timing of clinical data readoutsDelivered against core elements of our Roche-Genentech...
Community Leaders Unite to Provide Support and Resources for Thousands of Utahns with Rare Diseases
February 21, 2023 11:00 ET
|
Recursion Pharmaceuticals
Salt Lake City, Utah, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Rare Disease advocacy organizations and biotech and healthcare industry leaders will partner to accelerate the diagnosis and improve the care...